Here’s why Soligenix, Inc. (SNGX) stock is Popping High today
Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX stock price saw an uptrend of 10.26% to reach $1.29 a share at the time of this writing. The stock went high in the previous trading session following the receival of […]
Why Soligenix, Inc (SNGX) stock plummeted in the after-hours on Friday?
Soligenix Inc. (SNGX) shares sank 25.78% to trade at $0.95 in after-market on Friday, May 7, 2021. Earlier, SNGX’s stock price remained unchanged to close Friday’s session at $1.28. SNGX shares have declined 20.50% over the last 12 months, and they have moved down 11.11% in the past week. Over the past three months, the […]
Why Soligenix, Inc. (SNGX) Is Surging 16% In Pre-Market Session?
The biopharmaceutical company Soligenix, Inc. (Nasdaq: SNGX) has been surging +18.63% in the pre-market session today. As of 08:55 a.m. EST, the stock was buoying at $1.88 after gaining +0.27 on the trades of 11.05M shares. What actually happened? Soligenix focuses on developing, manufacturing and selling products for treating unmet medical needs related to rare […]
